Unidade de Nano-oncoloxía e Terapéutica Traslacional
University College London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de University College London (9)
2015
-
A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 2, pp. 369-377
2014
-
Optimisation of synthetic vector systems for cancer gene therapy - the role of the excess of cationic dendrimer under physiological conditions
Current Topics in Medicinal Chemistry, Vol. 14, Núm. 9, pp. 1172-1181
2013
-
Functional characterization of heat shock protein 90 targeted compounds
Analytical Biochemistry, Vol. 438, Núm. 2, pp. 107-109
-
GC-Targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models
Journal of Medicinal Chemistry, Vol. 56, Núm. 7, pp. 2911-2935
-
Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule
Scientific Reports, Vol. 3
2012
-
Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1683-1696
-
Hydration forces as a tool for the optimization of core-shell nanoparticle vectors for cancer gene therapy
Soft Matter, Vol. 8, Núm. 48, pp. 12080-12092
2010
-
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
Advanced Drug Delivery Reviews, Vol. 62, Núm. 1, pp. 100-117
-
Modified glycol chitosan nanocarriers carry hydrophobic materials into tumours
Nanotechnology 2010: Bio Sensors, Instruments, Medical, Environment and Energy - Technical Proceedings of the 2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2010